We help Support at Home-approved families find care.
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

Preventing pneumonia in elderly this winter

There are calls for the frail and elderly not to be overlooked for vaccines against pneumonia this winter, with University of NSW (UNSW) research challenging conventional wisdom on immunisation effectiveness in older patients.

Posted
by DPS

The UNSW led research demonstrated that even older, frail hospital patients with low baseline immunity are able to generate a significant response to pneumococcal vaccines.

Pneumonia is one of Australia’s leading causes of death, ranking in the top 20 in 2012 and is more common in winter. It is especially dangerous in young children and the elderly. In high risk groups such as the hospitalised frail elderly, mortality is greater than 50%.

Previous work has shown that the frail elderly are significantly less likely to be offered vaccines than other patients – those older than 80 are 30% less likely to be immunised and dementia patients are 70% less likely. This may be because doctors are not confident such patients can mount a sufficient immune response to vaccines.

But a randomised controlled trial, examining two different pneumococcal vaccines (23vPPV and PCV7) in frail hospitalised elderly, found that both can elicit a robust reaction from those with low baseline immunity, and there is a greater and more sustained response when the two vaccines are used together, in sequence.

“This study offers hope for novel combinations of the old and new vaccines for prevention of pneumococcal disease in this vulnerable group,” says Professor Raina MacIntyre, head of UNSW’s School of Public Health and Community Medicine.

The finding, published in PLoS One, is an important discovery given those with the lowest immunity are at greatest risk of developing invasive pneumococcal disease — the most common bacterial cause of pneumonia – and shows there is a case for vaccinating older patients.

As well as pneumonia, pneumococcal disease (an infection with the bacterium Streptococcus pneumoniae) can cause middle ear and sinus infections, meningitis and septicaemia.

The majority of deaths occur in those aged 65 years or older, and most cases are preventable by vaccination.

“Vaccination against preventable diseases is low hanging fruit as a strategy for healthy ageing, and no elderly person should be denied vaccination simply because immunity wanes with age,” Professor MacIntyre says.

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo